• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型预测指标与终末期肝病模型(MELD)及Child-Turcotte-Pugh(CTP)评分在预测肝硬化患者30天死亡率方面的比较

A Novel Predictor Compared to the Model for End-Stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) Scores for Predicting 30-Day Mortality in Patients With Liver Cirrhosis.

作者信息

Dewi Ni Nyoman Gita Kharisma, Mariadi I Ketut, Dewi Ni Luh Putu Yunia, Pamungkas Kadek Mercu Narapati, Dewi Putu Itta Sandi Lesmana, Sindhughosa Dwijo A

机构信息

Division of Gastroenterology and Hepatology, Centre Research for Alimentary and Hepatobiliary System, Denpasar, IDN.

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Udayana University, Denpasar, IDN.

出版信息

Cureus. 2025 Mar 30;17(3):e81446. doi: 10.7759/cureus.81446. eCollection 2025 Mar.

DOI:10.7759/cureus.81446
PMID:40303541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12038375/
Abstract

Background Liver cirrhosis (LC) is characterized by the development of fibrosis and nodules within the liver, leading to progressive liver dysfunction. The mortality rate associated with LC has consistently remained high over the years. Prognostic tools such as the Child-Turcotte-Pugh (CTP) score and the Model for End-Stage Liver Disease (MELD) score are commonly used to predict mortality and assess the severity of LC. Both scoring systems rely on laboratory parameters, including serum albumin, total bilirubin, and international normalized ratio (INR) levels. However, the CTP score interpretation can be variable, and INR testing is not routinely performed in many clinical settings, which may limit its utility. This study aims to assess the MELD and CTP scores, along with a new predictive tool, in estimating 30-day mortality for patients with LC. Methodology This retrospective cohort study focuses on patients diagnosed with LC at Ngoerah Central General Hospital. Physical examination data and laboratory ratios, including neutrophil-to-lymphocyte ratio (NLR), aspartate transaminase (AST) to alanine transaminase (ALT) ratio (de Ritis), neutrophil-to-lymphocyte-to-albumin (NLA) ratio, albumin bilirubin index (ALBI), and blood urea nitrogen-to-albumin ratio (BAR), were collected from medical records. Optimal cutoff values were established using receiver operating characteristic (ROC) curves. Survival analysis was performed using the Kaplan-Meier method, and multivariate Cox regression was employed to determine the hazard ratio (HR) for each variable that was statistically significant as a predictor of 30-day mortality. Results In this study, a total of 140 samples were analyzed. Kaplan-Meier analysis revealed that hepatic encephalopathy (HE) met the criteria, while interaction analysis testing was required for other variables. Results from the multivariate Cox regression interaction model showed that ALBI-HE (HR = 1.743, 95% confidence interval [CI] 1.102-2.759, = 0.018), BAR-HE (HR = 0.577, 95% CI 0.367-0.905, = 0.017), and NLA-HE (HR = 0.332, 95% CI 0.195-0.563, < 0.001) were significant independent predictors of 30-day mortality in LC. CTP, MELD, NLR, and de Ritis did not demonstrate statistical significance. ALBI-HE emerged as the strongest predictor based on its HR. Conclusions ALBI-HE, BAR-HE, and NLA-HE have emerged as novel predictors for assessing 30-day mortality in LC. ALBI-HE is the strongest predictor of 30-day mortality in LC.

摘要

背景 肝硬化(LC)的特征是肝脏内出现纤维化和结节,导致肝功能进行性减退。多年来,与LC相关的死亡率一直居高不下。诸如Child-Turcotte-Pugh(CTP)评分和终末期肝病模型(MELD)评分等预后工具通常用于预测死亡率和评估LC的严重程度。这两种评分系统均依赖于实验室参数,包括血清白蛋白、总胆红素和国际标准化比值(INR)水平。然而,CTP评分的解读可能存在差异,并且在许多临床环境中并非常规进行INR检测,这可能会限制其效用。本研究旨在评估MELD和CTP评分以及一种新的预测工具在估计LC患者30天死亡率方面的作用。

方法 这项回顾性队列研究聚焦于在恩戈拉中央综合医院被诊断为LC的患者。从病历中收集体格检查数据和实验室比值,包括中性粒细胞与淋巴细胞比值(NLR)、天冬氨酸转氨酶(AST)与丙氨酸转氨酶(ALT)比值(德里斯比值)、中性粒细胞与淋巴细胞与白蛋白比值(NLA)、白蛋白胆红素指数(ALBI)以及血尿素氮与白蛋白比值(BAR)。使用受试者工作特征(ROC)曲线确定最佳截断值。采用Kaplan-Meier方法进行生存分析,并使用多变量Cox回归确定作为30天死亡率预测指标具有统计学意义的每个变量的风险比(HR)。

结果 在本研究中,共分析了140个样本。Kaplan-Meier分析显示肝性脑病(HE)符合标准,而其他变量需要进行交互分析测试。多变量Cox回归交互模型的结果表明,ALBI-HE(HR = 1.743,95%置信区间[CI] 1.102 - 2.759,P = 0.018)、BAR-HE(HR = 0.577,95% CI 0.367 - 0.905,P = 0.017)和NLA-HE(HR = 0.332,95% CI 0.195 - 0.563,P < 0.001)是LC患者30天死亡率的显著独立预测指标。CTP、MELD、NLR和德里斯比值未显示出统计学意义。基于其HR,ALBI-HE成为最强的预测指标。

结论 ALBI-HE、BAR-HE和NLA-HE已成为评估LC患者30天死亡率的新预测指标。ALBI-HE是LC患者30天死亡率的最强预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c509/12038375/4ee310a2b9a2/cureus-0017-00000081446-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c509/12038375/2699369a5d6f/cureus-0017-00000081446-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c509/12038375/4ee310a2b9a2/cureus-0017-00000081446-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c509/12038375/2699369a5d6f/cureus-0017-00000081446-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c509/12038375/4ee310a2b9a2/cureus-0017-00000081446-i02.jpg

相似文献

1
A Novel Predictor Compared to the Model for End-Stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) Scores for Predicting 30-Day Mortality in Patients With Liver Cirrhosis.一种新型预测指标与终末期肝病模型(MELD)及Child-Turcotte-Pugh(CTP)评分在预测肝硬化患者30天死亡率方面的比较
Cureus. 2025 Mar 30;17(3):e81446. doi: 10.7759/cureus.81446. eCollection 2025 Mar.
2
Predicting Mortality Across a Broad Spectrum of Liver Disease-An Assessment of Model for End-Stage Liver Disease (MELD), Child-Turcotte-Pugh (CTP), and Creatinine-Modified CTP Scores.预测广泛肝病患者的死亡率——对终末期肝病模型(MELD)、Child-Turcotte-Pugh(CTP)评分以及肌酐修正CTP评分的评估
J Clin Exp Hepatol. 2011 Dec;1(3):161-8. doi: 10.1016/S0973-6883(11)60233-8. Epub 2012 Jan 2.
3
Albumin-Bilirubin (ALBI) as an accurate and simple prognostic score for chronic hepatitis B-related liver cirrhosis.白蛋白-胆红素(ALBI)评分作为一种准确而简单的慢性乙型肝炎相关肝硬化的预后评分。
Dig Liver Dis. 2019 Aug;51(8):1172-1178. doi: 10.1016/j.dld.2019.01.011. Epub 2019 Jan 26.
4
Prevalence of and Factors Associated With Minimal Hepatic Encephalopathy in Patients With Cirrhosis of Liver.肝硬化患者轻微肝性脑病的患病率及相关因素
J Clin Exp Hepatol. 2018 Jun;8(2):156-161. doi: 10.1016/j.jceh.2017.06.005. Epub 2017 Jun 20.
5
The ability of the new ALBI scoring in predicting mortality, complications and prognostic comparison among cirrhotics.新型ALBI评分在预测肝硬化患者死亡率、并发症及预后比较方面的能力。
Prz Gastroenterol. 2019;14(4):250-257. doi: 10.5114/pg.2019.83872. Epub 2019 Mar 25.
6
Hematological Indices Are Useful in Predicting Complications of Liver Cirrhosis.血液学指标有助于预测肝硬化并发症。
J Clin Med. 2023 Jul 21;12(14):4820. doi: 10.3390/jcm12144820.
7
Integrated model for end-stage liver disease maybe superior to some other model for end-stage liver disease-based systems in addition to Child-Turcotte-Pugh and albumin-bilirubin scores in patients with hepatitis B virus-related liver cirrhosis and spontaneous bacterial peritonitis.终末期肝病模型或许优于其他基于终末期肝病模型的系统,包括 Child-Turcotte-Pugh 评分和白蛋白-胆红素评分,在乙型肝炎病毒相关性肝硬化和自发性细菌性腹膜炎患者中。
Eur J Gastroenterol Hepatol. 2019 Oct;31(10):1256-1263. doi: 10.1097/MEG.0000000000001481.
8
[Clinical significance of CTP combined with ABIC score in predicting the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure].CTP联合ABIC评分对预测乙型肝炎病毒相关性慢加急性肝衰竭患者短期预后的临床意义
Zhonghua Gan Zang Bing Za Zhi. 2019 Feb 20;27(2):118-122. doi: 10.3760/cma.j.issn.1007-3418.2019.02.009.
9
Value of the albumin-bilirubin score in the evaluation of hepatitis B virus-related acute-on-chronic liver failure, liver cirrhosis, and hepatocellular carcinoma.白蛋白-胆红素评分在评估乙型肝炎病毒相关慢加急性肝衰竭、肝硬化和肝细胞癌中的价值。
Exp Ther Med. 2018 Mar;15(3):3074-3079. doi: 10.3892/etm.2018.5748. Epub 2018 Jan 12.
10
Neutrophil to Lymphocyte Ratio (NLR) and its Correlation with Child Turcotte Pugh (CTP) Score in Prediciting Severity of Decompensated Liver Cirrhosis.中性粒细胞与淋巴细胞比值(NLR)及其与 Child Turcotte Pugh(CTP)评分在预测失代偿期肝硬化严重程度中的相关性。
J Assoc Physicians India. 2022 Apr;70(4):11-12.

本文引用的文献

1
Infection, inflammation and hepatic encephalopathy from a clinical perspective.从临床角度看感染、炎症与肝性脑病。
Metab Brain Dis. 2024 Dec;39(8):1689-1703. doi: 10.1007/s11011-024-01402-y. Epub 2024 Aug 30.
2
Navigating Disease Management: A Comprehensive Review of the De Ritis Ratio in Clinical Medicine.疾病管理指南:临床医学中德瑞蒂斯比值的全面综述
Cureus. 2024 Jul 13;16(7):e64447. doi: 10.7759/cureus.64447. eCollection 2024 Jul.
3
Hematological Indices Are Useful in Predicting Complications of Liver Cirrhosis.血液学指标有助于预测肝硬化并发症。
J Clin Med. 2023 Jul 21;12(14):4820. doi: 10.3390/jcm12144820.
4
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study.肝性脑病增加失代偿期肝硬化患者的死亡风险和再入院风险:一项前瞻性多中心研究。
Front Med (Lausanne). 2023 May 25;10:1184860. doi: 10.3389/fmed.2023.1184860. eCollection 2023.
5
Diagnosis and Management of Cirrhosis and Its Complications: A Review.肝硬化及其并发症的诊断与管理:综述。
JAMA. 2023 May 9;329(18):1589-1602. doi: 10.1001/jama.2023.5997.
6
Global epidemiology of cirrhosis - aetiology, trends and predictions.全球肝硬化的流行病学:病因、趋势和预测。
Nat Rev Gastroenterol Hepatol. 2023 Jun;20(6):388-398. doi: 10.1038/s41575-023-00759-2. Epub 2023 Mar 28.
7
Epidemiology of liver cirrhosis and associated complications: Current knowledge and future directions.肝硬化及其相关并发症的流行病学:当前知识和未来方向。
World J Gastroenterol. 2022 Nov 7;28(41):5910-5930. doi: 10.3748/wjg.v28.i41.5910.
8
Liver cirrhosis and immune dysfunction.肝硬化和免疫功能障碍。
Int Immunol. 2022 Sep 6;34(9):455-466. doi: 10.1093/intimm/dxac030.
9
Editorial: The Microbiome in Hepatobiliary and Intestinal Disease.社论:肝胆与肠道疾病中的微生物组
Front Physiol. 2022 Apr 13;13:893074. doi: 10.3389/fphys.2022.893074. eCollection 2022.
10
Prognostic value of albumin-related ratios in HBV-associated decompensated cirrhosis.白蛋白相关比值对乙型肝炎相关性失代偿性肝硬化的预后价值。
J Clin Lab Anal. 2022 Apr;36(4):e24338. doi: 10.1002/jcla.24338. Epub 2022 Mar 17.